The FDA and Alzheimer’s

Thank you so much for listening to the Bob Harden Show, celebrating over nine years broadcasting weekdays on the internet – providing you news and commentary based on the principles of individual liberty, personal responsibility, limited government and the rule of law.

On Friday’s show, we visit with William Yeatman, Research Fellow with the Cato Institute, about the continuing negotiations on the “infrastructure” bill, and we discuss Biden’s current narrowing path to big spending and bigger government. We visit with the Director of Health Studies at the Cato Institute, Michael Cannon, about Biogen’s newly approved Alzheimer’s drug.  The President & CEO of the James Madison Institute, Dr. Bob McClure, and I discuss the success of Florida, Governor DeSantis, and the last legislative session. We also visit with Dave Bego, Founder and CEO of Executive Management Services author of “The Devil at Our Doorstep” about unions under the Biden administration.

Please join us for Monday’s show. We have terrific guests including the Founder and Publisher of HistoryCentral.com, Marc Schulman, former Barron’s Washington Bureau Chief, Jim McTague, and the President Emeritus of the Foundation for Economic Education, Larry Reed.

Please join us live at 7 a.m. on this website, or you can access the show anytime on podcast platforms (iTunes, TuneIn, Spotify, and Stitcher, ChoiceSocial and Vurbl).

Click on the Link to Listen:

https://www.dropbox.com/s/a881ssccnhnj7y6/6_11_21.mp3?dl=0 

Check Also

Does Transitioning to Alternative Energy Make Sense?

Thank you so much for listening to the Bob Harden Show, celebrating over ten years …